Vyome gets USPTO notice of allowance for VT-1908 topical mycophenolate patent application

PUBT · 3d ago
Vyome gets USPTO notice of allowance for VT-1908 topical mycophenolate patent application
  • Vyome received a USPTO Notice of Allowance for a U.S. patent application covering VT-1908, a topical ophthalmic mycophenolate program.
  • Claims cover formulations and methods of use for inflammatory diseases, supporting IP protection around the candidate’s development plans.
  • VT-1908 is being developed initially for anterior uveitis, targeting demand for steroid-sparing therapies in ocular inflammation.
  • Vyome estimates the broader ocular inflammation market at more than $20 billion by 2035.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005278681) on October 05, 2026, and is solely responsible for the information contained therein.